Evidence map›Paper›PMID 38745665›Full record

ArticleFrontiers in immunology2024

A two-dose viral-vectored

Yutaro Yamamoto, Camila Fabbri, Daiki Okuhara, Rina Takagi, Yuna Kawabata, Takuto Katayama, Mitsuhiro Iyori, Ammar A Hasyim, Akihiko Sakamoto, Hiroaki Mizukami and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yutaro YamamotoLaboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.
Camila FabbriInstituto Leônidas & Maria Deane/Fiocruz Amazônia, Laboratório de Diagnóstico e Controle e Doenças Infecciosas da Amazônia, Manaus, Amazonas, Brazil.
Daiki OkuharaLaboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.
Rina TakagiLaboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.
Yuna KawabataLaboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.
Takuto KatayamaLaboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.
Mitsuhiro IyoriDepartment of Pharmaceutical Sciences, Musashino University, Tokyo, Japan.
Ammar A HasyimLaboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.
Akihiko SakamotoLaboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.
Hiroaki MizukamiDivision of Genetic Therapeutics, Jichi Medical University, Shimono, Tochigi, Japan.
Hisatoshi ShidaLaboratory of Primate Model, Research Center for Infectious Diseases, Institute for Frontier Life and Medical Science, Kyoto University, Kyoto, Japan.
Stefanie LopesInstituto Leônidas & Maria Deane/Fiocruz Amazônia, Laboratório de Diagnóstico e Controle e Doenças Infecciosas da Amazônia, Manaus, Amazonas, Brazil.
Shigeto YoshidaLaboratory of Vaccinology and Applied Immunology, Kanazawa University School of Pharmacy, Kanazawa University, Kanazawa, Ishikawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among

Indexed as

DependovirusGenetic VectorsMalaria VaccinesMalaria, VivaxPlasmodium vivaxAnimalsAntibodies, ProtozoanDisease Models, AnimalFemaleHumansImmunization, SecondaryMiceMice, Inbred BALB CProtozoan ProteinsVaccine EfficacyVaccinia virusAntibodies, ProtozoanMalaria VaccinesProtozoan Proteinsadeno-associated virusLC16m8ΔmalariaPlasmodium vivaxPvCSPPvs25vaccine

Identifiers

PMID38745665
PMCPMC11091281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.